跳至主要内容
临床试验/NCT06074874
NCT06074874已完成不适用

Intestinal Biomarker Analysis After ECP for ICI Colitis

University of Freiburg1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
T cell number and phenotype measurement in the intestinal tract

研究概览

简要总结

It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the chnages of immune cells in the peripheral blood and intestinal tract in an ICI colitis patient cohort. The analysis will include the evaluation of intestinal and peripheral blood biomarkers in patients with ICI colitis receiving ECP as a treatment.

详细描述

It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the changes of immune cells in the peripheral blood and intestinal tract in an ICI colitis patient cohort. The analysis will include the evaluation of intestinal and peripheral blood biomarkers in patients with ICI colitis receiving ECP as a treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ICI colitis

排除标准

  • no informed consent

结局指标

主要结局

T cell number and phenotype measurement in the intestinal tract

时间窗: 6 months

Analysis of CD3+ T cells by flow cytometry

次要结局

  • T cell number measurement by immunohistochemistry(6 months)
  • Analysis of arginase amounts in the intestinal tract using qPCR(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Zeiser

Director Division of Tumor immunology

University of Freiburg

研究点 (1)

Loading locations...

相似试验

Intestinal Biomarker Analysis After ECP for ICI... | 临床试验